The Exon 3-Deleted Growth Hormone Receptor (d3GHR) Polymorphism—A Favorable Backdoor Mechanism for the GHR Function
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241813908 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ghadeer Falah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Natural Sciences, University of Haifa, Haifa 3498838, Israel. Hauptthemen laut MEDLINE: Receptors, Somatotropin, Exons, Polymorphism, Genetic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Growth hormone (GH) is a peptide hormone that plays a crucial role in controlling growth, development, and lifespan. Molecular regulation of GH is accomplished via the GH receptor (GHR), which is the main factor influencing human development and is essential to optimal functioning of the GH/IGF-I axis. Two GHR isoforms have been studied, according to the presence (flGHR) or absence (d3GHR) of exon 3. The d3GHR isoform, which lacks exon 3 has recently been related to longevity; individuals carrying this isoform have higher receptor activity, improved signal transduction, and alterations in the treatment response and efficacy compared with those carrying the wild type (WT) isoform (flGHR). Further, studies performed in patients with acromegaly, Prader–Willi syndrome, Turner syndrome, small for gestational age (SGA), and growth hormone deficiency (GHD) suggested that the d3GHR isoform may have an impact on the relationship between GH and IGF-I levels, height, weight, BMI, and other variables. Other research, however, revealed inconsistent results, which might have been caused by confounding factors, including limited sample sizes and different experimental methods. In this review, we lay out the complexity of the GHR isoforms and provide an overview of the major pharmacogenetic research conducted on this ongoing and unresolved subject.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Natural Sciences, University of Haifa, Haifa 3498838, Israel.
- Departments of Medicine and Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
ORCID-Profile: Ghadeer Falah, Lital Sharvit, Gil Atzmon
Zitieren
APA
Falah, G., Sharvit, L., & Atzmon, G. (2023). The Exon 3-Deleted Growth Hormone Receptor (d3GHR) Polymorphism—A Favorable Backdoor Mechanism for the GHR Function. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241813908
Vancouver
Falah G, Sharvit L, Atzmon G. The Exon 3-Deleted Growth Hormone Receptor (d3GHR) Polymorphism—A Favorable Backdoor Mechanism for the GHR Function. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241813908
BibTeX
@article{Falah2023,
author = {Falah, Ghadeer and Sharvit, Lital and Atzmon, Gil},
title = {The Exon 3-Deleted Growth Hormone Receptor (d3GHR) Polymorphism—A Favorable Backdoor Mechanism for the GHR Function},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241813908}
}
EUVIMED